Loading...

Nufarm

OTCPK:NFRM.Y
Snowflake Description

Fair value with moderate growth potential.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
NFRM.Y
OTCPK
A$2B
Market Cap
  1. Home
  2. US
  3. Materials
Company description

Nufarm Limited, together with its subsidiaries, manufactures and sells crop protection products in Australia, New Zealand, Asia, Europe, North America, and Latin America. The last earnings update was 58 days ago. More info.


Add to Portfolio Compare Print
  • Nufarm has significant price volatility in the past 3 months.
NFRM.Y Share Price and Events
7 Day Returns
0%
OTCPK:NFRM.Y
-2.9%
US Chemicals
-3.9%
US Market
1 Year Returns
-47.8%
OTCPK:NFRM.Y
-15.1%
US Chemicals
1.4%
US Market
NFRM.Y Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Nufarm (NFRM.Y) 0% 0% -24.1% -47.8% - -
US Chemicals -2.9% -8.1% -8.7% -15.1% 13.9% 6%
US Market -3.9% -3.6% 1.8% 1.4% 35.8% 40.8%
1 Year Return vs Industry and Market
  • NFRM.Y underperformed the Chemicals industry which returned -15.1% over the past year.
  • NFRM.Y underperformed the Market in United States of America which returned 1.4% over the past year.
Price Volatility
NFRM.Y
Industry
5yr Volatility vs Market
Related Companies

NFRM.Y Value

 Is Nufarm undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Nufarm to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Nufarm.

OTCPK:NFRM.Y Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 12 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 11%
Perpetual Growth Rate 10-Year US Government Bond Rate 2.7%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for OTCPK:NFRM.Y
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year US Govt Bond Rate 2.7%
Equity Risk Premium S&P Global 6%
Chemicals Unlevered Beta Simply Wall St/ S&P Global 0.88
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.875 (1 + (1- 30%) (113.23%))
1.381
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
1.38
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 2.73% + (1.381 * 5.96%)
10.96%

Discounted Cash Flow Calculation for OTCPK:NFRM.Y using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Nufarm is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

OTCPK:NFRM.Y DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (AUD, Millions) Source Present Value
Discounted (@ 10.96%)
2019 94.00 Analyst x1 84.71
2020 275.50 Analyst x2 223.75
2021 305.50 Analyst x2 223.60
2022 271.00 Analyst x1 178.75
2023 283.00 Analyst x1 168.23
2024 284.48 Est @ 0.52% 152.40
2025 287.85 Est @ 1.18% 138.97
2026 292.60 Est @ 1.65% 127.30
2027 298.37 Est @ 1.97% 116.99
2028 304.93 Est @ 2.2% 107.75
Present value of next 10 years cash flows A$1,522.46
OTCPK:NFRM.Y DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2028 × (1 + g) ÷ (Discount Rate – g)
= A$304.93 × (1 + 2.73%) ÷ (10.96% – 2.73%)
A$3,804.87
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= A$3,804.87 ÷ (1 + 10.96%)10
A$1,344.49
OTCPK:NFRM.Y Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= A$1,522.46 + A$1,344.49
A$2,866.95
Equity Value per Share
(AUD)
= Total value / Shares Outstanding
= A$2,866.95 / 379.64
A$7.55
OTCPK:NFRM.Y Discount to Share Price
Calculation Result
Non-primary Listing Adjustment Factor 1 share in OTCPK:NFRM.Y represents 0.80717x of ASX:NUF
(This could be a different class, a depositary receipt, a different currency, or all of these things.)
0.80717x
Value per Share
(Listing Adjusted, USD)
= Value per Share (AUD) x Listing Adjustment Factor
= A$ 7.55 x 0.80717
$6.10
Value per share (USD) From above. $6.10
Current discount Discount to share price of $3.60
= -1 x ($3.60 - $6.10) / $6.10
40.9%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price Nufarm is available for.
Intrinsic value
41%
Share price is $3.6 vs Future cash flow value of $6.1
Current Discount Checks
For Nufarm to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • Nufarm's share price is below the future cash flow value, and at a moderate discount (> 20%).
  • Nufarm's share price is below the future cash flow value, and at a substantial discount (> 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Nufarm's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Nufarm's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
OTCPK:NFRM.Y PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-01-31) in AUD A$-0.15
ASX:NUF Share Price ** ASX (2019-03-29) in AUD A$4.46
United States of America Chemicals Industry PE Ratio Median Figure of 67 Publicly-Listed Chemicals Companies 17.79x
United States of America Market PE Ratio Median Figure of 3,087 Publicly-Listed Companies 17.79x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Nufarm.

OTCPK:NFRM.Y PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= ASX:NUF Share Price ÷ EPS (both in AUD)

= 4.46 ÷ -0.15

-29.38x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Nufarm is loss making, we can't compare its value to the US Chemicals industry average.
  • Nufarm is loss making, we can't compare the value of its earnings to the United States of America market.
Price based on expected Growth
Does Nufarm's expected growth come at a high price?
Raw Data
OTCPK:NFRM.Y PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -29.38x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 12 Analysts
29.1%per year
United States of America Chemicals Industry PEG Ratio Median Figure of 50 Publicly-Listed Chemicals Companies 1.33x
United States of America Market PEG Ratio Median Figure of 2,113 Publicly-Listed Companies 1.52x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Nufarm, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Nufarm's assets?
Raw Data
OTCPK:NFRM.Y PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-01-31) in AUD A$5.23
ASX:NUF Share Price * ASX (2019-03-29) in AUD A$4.46
United States of America Chemicals Industry PB Ratio Median Figure of 92 Publicly-Listed Chemicals Companies 2.14x
United States of America Market PB Ratio Median Figure of 5,195 Publicly-Listed Companies 1.83x
OTCPK:NFRM.Y PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= ASX:NUF Share Price ÷ Book Value per Share (both in AUD)

= 4.46 ÷ 5.23

0.85x

* Primary Listing of Nufarm.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Nufarm is good value based on assets compared to the US Chemicals industry average.
X
Value checks
We assess Nufarm's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Chemicals industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Chemicals industry average (and greater than 0)? (1 check)
  5. Nufarm has a total score of 3/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

NFRM.Y Future Performance

 How is Nufarm expected to perform in the next 1 to 3 years based on estimates from 12 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
29.1%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Nufarm expected to grow at an attractive rate?
  • Nufarm's earnings growth is expected to exceed the low risk savings rate of 2.7%.
Growth vs Market Checks
  • Nufarm's earnings growth is expected to exceed the United States of America market average.
  • Nufarm's revenue growth is positive but not above the United States of America market average.
Annual Growth Rates Comparison
Raw Data
OTCPK:NFRM.Y Future Growth Rates Data Sources
Data Point Source Value (per year)
OTCPK:NFRM.Y Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 12 Analysts 29.1%
OTCPK:NFRM.Y Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 12 Analysts 4.3%
United States of America Chemicals Industry Earnings Growth Rate Market Cap Weighted Average 13.4%
United States of America Chemicals Industry Revenue Growth Rate Market Cap Weighted Average 4.1%
United States of America Market Earnings Growth Rate Market Cap Weighted Average 14%
United States of America Market Revenue Growth Rate Market Cap Weighted Average 7.3%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
OTCPK:NFRM.Y Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 12 Analyst Estimates (S&P Global) See Below
All numbers in AUD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
OTCPK:NFRM.Y Future Estimates Data
Date (Data in AUD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2023-07-31 4,196 262 2
2022-07-31 4,060 243 2
2021-07-31 3,942 330 182 11
2020-07-31 3,799 322 155 11
2019-07-31 3,583 256 97 12
OTCPK:NFRM.Y Past Financials Data
Date (Data in AUD Millions) Revenue Cash Flow Net Income *
2019-01-31 3,424 -281 -52
2018-10-31 3,366 -185 -39
2018-07-31 3,308 -88 -26
2018-04-30 3,260 -41 35
2018-01-31 3,211 5 96
2017-10-31 3,161 30 99
2017-07-31 3,111 55 103
2017-04-30 3,037 146 115
2017-01-31 2,964 236 127
2016-10-31 2,877 187 72
2016-07-31 2,791 137 16
2016-04-30 2,766 166 -33

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Nufarm's earnings are expected to grow significantly at over 20% yearly.
  • Nufarm's revenue is expected to grow by 4.3% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
OTCPK:NFRM.Y Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 12 Analyst Estimates (S&P Global) See Below

All data from Nufarm Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

OTCPK:NFRM.Y Future Estimates Data
Date (Data in AUD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2023-07-31 0.67 0.76 0.58 2.00
2022-07-31 0.62 0.70 0.54 2.00
2021-07-31 0.48 0.65 0.38 8.00
2020-07-31 0.40 0.54 0.31 7.00
2019-07-31 0.26 0.34 0.22 6.00
OTCPK:NFRM.Y Past Financials Data
Date (Data in AUD Millions) EPS *
2019-01-31 -0.15
2018-10-31 -0.12
2018-07-31 -0.08
2018-04-30 0.12
2018-01-31 0.34
2017-10-31 0.36
2017-07-31 0.39
2017-04-30 0.43
2017-01-31 0.48
2016-10-31 0.27
2016-07-31 0.06
2016-04-30 -0.13

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Nufarm is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
X
Future performance checks
We assess Nufarm's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Nufarm has a total score of 3/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

NFRM.Y Past Performance

  How has Nufarm performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Nufarm's growth in the last year to its industry (Chemicals).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Nufarm does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare Nufarm's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Nufarm's 1-year growth to the US Chemicals industry average as it is not currently profitable.
Earnings and Revenue History
Nufarm's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Nufarm Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

OTCPK:NFRM.Y Past Revenue, Cash Flow and Net Income Data
Date (Data in AUD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-01-31 3,423.83 -52.09 721.97 34.32
2018-10-31 3,365.84 -39.22 694.29 36.68
2018-07-31 3,307.85 -26.35 666.62 39.05
2018-04-30 3,259.51 34.60 640.78 38.42
2018-01-31 3,211.18 95.55 614.95 37.79
2017-10-31 3,161.15 99.36 600.18 39.05
2017-07-31 3,111.12 103.17 585.41 40.32
2017-04-30 3,037.40 115.10 570.26 40.83
2017-01-31 2,963.68 127.02 555.12 41.35
2016-10-31 2,877.45 71.59 534.88 40.34
2016-07-31 2,791.22 16.16 514.64 39.34
2016-04-30 2,766.13 -33.30 517.11 37.05
2016-01-31 2,741.04 -82.77 519.59 34.77
2015-10-31 2,739.10 -25.90 514.04 33.73
2015-07-31 2,737.16 30.96 508.49 32.68
2015-04-30 2,702.69 30.45 496.63 32.30
2015-01-31 2,668.22 29.94 484.77 31.92
2014-10-31 2,645.46 27.64 479.59 35.47
2014-07-31 2,622.70 25.34 474.41 39.03
2014-04-30 2,551.90 51.93 460.31 44.45
2014-01-31 2,481.09 78.51 446.22 49.86
2013-10-31 2,379.19 72.77 430.32 46.28
2013-07-31 2,277.29 67.03 414.42 42.70
2013-04-30 2,265.28 57.54 406.45 40.23
2013-01-31 2,253.26 48.06 398.49 37.76
2012-10-31 2,217.41 53.30 391.67 37.82
2012-07-31 2,181.55 58.55 384.85 37.87

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Nufarm has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • Nufarm used its assets less efficiently than the US Chemicals industry average last year based on Return on Assets.
  • It is difficult to establish if Nufarm improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Nufarm's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Chemicals industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Nufarm has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

NFRM.Y Health

 How is Nufarm's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Nufarm's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Nufarm is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Nufarm's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Nufarm's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 1.8x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Nufarm Company Filings, last reported 3 months ago.

OTCPK:NFRM.Y Past Debt and Equity Data
Date (Data in AUD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-01-31 2,232.64 1,917.27 340.14
2018-10-31 2,232.64 1,917.27 340.14
2018-07-31 1,971.62 1,675.77 301.70
2018-04-30 1,971.62 1,675.77 301.70
2018-01-31 2,021.58 936.24 392.43
2017-10-31 2,021.58 936.24 392.43
2017-07-31 1,602.92 915.44 235.15
2017-04-30 1,602.92 915.44 235.15
2017-01-31 1,534.43 1,109.78 253.39
2016-10-31 1,534.43 1,109.78 253.39
2016-07-31 1,550.23 906.88 320.01
2016-04-30 1,550.23 906.88 320.01
2016-01-31 1,464.24 1,210.73 283.70
2015-10-31 1,464.24 1,210.73 283.70
2015-07-31 1,636.80 938.14 391.42
2015-04-30 1,636.80 938.14 391.42
2015-01-31 1,669.16 1,182.18 292.57
2014-10-31 1,669.16 1,182.18 292.57
2014-07-31 1,608.70 776.10 241.64
2014-04-30 1,608.70 776.10 241.64
2014-01-31 1,650.24 1,239.60 217.05
2013-10-31 1,650.24 1,239.60 217.05
2013-07-31 1,664.75 920.40 264.97
2013-04-30 1,664.75 920.40 264.97
2013-01-31 1,500.89 959.11 216.53
2012-10-31 1,500.89 959.11 216.53
2012-07-31 1,476.80 659.12 191.32
  • Nufarm's level of debt (85.9%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has increased over the past 5 years (74.8% vs 85.9% today).
  • Operating cash flow is negative therefore debt is not well covered.
  • Nufarm is making a loss, therefore interest payments are not well covered by earnings.
X
Financial health checks
We assess Nufarm's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Nufarm has a total score of 2/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

NFRM.Y Dividends

 What is Nufarm's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Nufarm dividends. Estimated to be 3.04% next year.
If you bought $2,000 of Nufarm shares you are expected to receive $0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Nufarm's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Nufarm's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
OTCPK:NFRM.Y Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 12 Analyst Estimates (S&P Global) See Below
United States of America Chemicals Industry Average Dividend Yield Market Cap Weighted Average of 54 Stocks 2.3%
United States of America Market Average Dividend Yield Market Cap Weighted Average of 1997 Stocks 2.5%
United States of America Minimum Threshold Dividend Yield 10th Percentile 0.8%
United States of America Bottom 25% Dividend Yield 25th Percentile 1.5%
United States of America Top 25% Dividend Yield 75th Percentile 3.7%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

OTCPK:NFRM.Y Future Dividends Estimate Data
Date (Data in A$) Dividend per Share (annual) Avg. No. Analysts
2023-07-31 0.23 2.00
2022-07-31 0.22 2.00
2021-07-31 0.15 12.00
2020-07-31 0.12 11.00
2019-07-31 0.07 5.00
OTCPK:NFRM.Y Past Annualized Dividends Data
Date (Data in A$) Dividend per share (annual) Avg. Yield (%)
2019-03-19 0.000 0.000
2018-10-01 0.130 2.240
2018-03-20 0.130 1.604
2017-09-25 0.130 1.534
2017-03-21 0.120 1.276
2016-09-20 0.110 1.227
2015-09-22 0.100 1.303
2015-03-24 0.090 1.243
2014-09-22 0.080 1.519
2013-09-24 0.100 2.296
2013-03-28 0.060 1.336
2012-09-24 0.060 1.063
2012-03-27 0.060 1.164
2011-03-28 0.000 0.000
2010-09-28 0.000 0.000
2010-03-29 0.000 0.000
2009-09-28 0.270 2.570

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Nufarm has not reported any payouts.
  • Unable to verify if Nufarm's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Nufarm's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Nufarm has not reported any payouts.
Future Payout to shareholders
  • Dividends after 3 years are expected to be well covered by earnings (3.1x coverage).
X
Income/ dividend checks
We assess Nufarm's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Nufarm afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Nufarm has a total score of 1/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

NFRM.Y Management

 What is the CEO of Nufarm's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Greg Hunt
COMPENSATION A$1,851,114
AGE 59
TENURE AS CEO 4 years
CEO Bio

Mr. Gregory Allan Hunt, also known as Greg, Grad. Dip., Mgmnt, AMP Harvard, AICD, REBA, has been the Chief Executive Officer and Managing Director of Nufarm Limited since May 05, 2015. Mr. Hunt serves as Managing Director and Chief Executive Officer of Nufarm Australia Limited. He served as an Acting Chief Executive Officer of Nufarm Limited from February 4, 2015 to May 04, 2015 and served as its Chief Operating Officer. Mr. Hunt served as Group Executive of Commercial Operations at Nufarm Limited. Mr. Hunt served as Group Executive for Regional Crop Protection Businesses at Nufarm Limited since February 2014. Mr. Hunt served as Group Executive of Global Marketing and Business Development at Nufarm Limited. Mr. Hunt served as Group Executive Global Marketing and Business Development of Nufarm Limited and served as its Group General Manager of Global Marketing and Business Development since February 6, 2012. He has worked in the agribusiness industry for over 30 years and served as Chief Executive Officer of Elders Ltd. Mr. Hunt has considerable executive and agribusiness experience. He served as Managing Director of Elders Australia Ltd. at Elders Ltd. (also known as Futuris Corp. Ltd) from 2001 to July 13, 2007, where Mr. Hunt served a number of management positions focused on both the Australian and international operations and led its operations across a broad range of activity, including rural merchandising and product distribution. He worked with a number of organisations in business development and agribusiness related investment advisory roles and has assisted companies including Tandou Ltd, Plum Grove Pty Ltd and Biocentral laboratories Ltd. Mr. Hunt served as Managing Director of BWK Ag (Germany), Australian Agricultural Company Ltd., Killara Feedlot Pty Ltd., Webster Ltd., HiFert Pty Ltd., Walnuts Australia Pty Ltd., Elders Indonesia and Elders Insurance Ltd. Mr. Hunt serves as the Chairman of Elementree Pty Ltd., Biocentral Laboratories, Kirribilli Pastoral and Plumgrove Pty Ltd. He has been an Executive Director of Nufarm Limited since May 05, 2015. He serves as Director of Elders Insurance Limited, Elders Australia Limited, Commissioner PT Elders Indonesia. He served as Director of Costa Group Holdings Limited from October 07, 2011 to June 2015. Mr. Hunt served as a Non-executive Independent Director of Plum Grove Pty Ltd. Mr. Hunt served as Director of Elders Rural Bank Limited from July 2002 to July 14, 2006. He served as Independent Non-Executive Director of Tandou Ltd. from November 21, 2007 to February 29, 2012. Mr. Hunt served as a Non Executive Director of Webster Ltd. from January 23, 2004 to October 24, 2007. He served as Director of Tassal Group Ltd. until August 2005. Mr. Hunt attended Harvard University (AMP) and has Graduate Management Qualifications from Australian Institute of Company Directors.

CEO Compensation
  • Greg's compensation has been consistent with company performance over the past year.
  • Greg's remuneration is lower than average for companies of similar size in United States of America.
Management Team Tenure

Average tenure of the Nufarm management team in years:

4
Average Tenure
  • The tenure for the Nufarm management team is about average.
Management Team

Greg Hunt

TITLE
MD, CEO & Executive Director
COMPENSATION
A$2M
AGE
59
TENURE
4 yrs

Paul Binfield

TITLE
Chief Financial Officer
COMPENSATION
A$1M
AGE
53
TENURE
7.5 yrs

Rod Heath

TITLE
Group Executive of Corporate Services & Company Secretary
TENURE
19.3 yrs

Mark Keating

TITLE
General Manager of Investor Relations
TENURE
3.7 yrs

John Holding

TITLE
Group Executive of People & Performance
TENURE
1.3 yrs
Board of Directors Tenure

Average tenure and age of the Nufarm board of directors in years:

7.1
Average Tenure
62
Average Age
  • The tenure for the Nufarm board of directors is about average.
Board of Directors

Donald McGauchie

TITLE
Chairman
COMPENSATION
A$378K
AGE
68
TENURE
8.8 yrs

Greg Hunt

TITLE
MD, CEO & Executive Director
COMPENSATION
A$2M
AGE
59
TENURE
4 yrs

Gordon Davis

TITLE
Non-Executive Independent Director
COMPENSATION
A$202K
AGE
62
TENURE
8 yrs

Peter Margin

TITLE
Non-Executive Independent Director
COMPENSATION
A$198K
AGE
58
TENURE
7.6 yrs

Frank Ford

TITLE
Non-Executive Independent Director
COMPENSATION
A$191K
AGE
72
TENURE
6.6 yrs

Anne Brennan

TITLE
Non-Executive Independent Director
COMPENSATION
A$183K
AGE
58
TENURE
8.3 yrs

Toshikazu Takasaki

TITLE
Non-Executive Director
COMPENSATION
A$164K
AGE
71
TENURE
6.4 yrs

Marie McDonald

TITLE
Non-Executive Director
COMPENSATION
A$184K
AGE
62
TENURE
2.2 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price ($) Value ($)
X
Management checks
We assess Nufarm's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Nufarm has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

NFRM.Y News

Simply Wall St News

NFRM.Y Company Info

Description

Nufarm Limited, together with its subsidiaries, manufactures and sells crop protection products in Australia, New Zealand, Asia, Europe, North America, and Latin America. It operates through two segments, Crop Protection and Seed Technologies. The company offers herbicides, insecticides, and fungicides to protect crops from damage caused by weeds, pests, and diseases. It also provides seeds and seed treatment products; and engages in croplands equipment business. The company is headquartered in Laverton North, Australia.

Details
Name: Nufarm Limited
NFRM.Y
Exchange: OTCPK
Founded:
A$1,173,626,831
379,639,334
Website: http://www.nufarm.com
Address: Nufarm Limited
103-105 Pipe Road,
Laverton North,
Victoria, 3026,
Australia
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
ASX NUF Ordinary Shares Australian Securities Exchange AU AUD 02. Jan 1992
OTCPK NUFM.F Ordinary Shares Pink Sheets LLC US USD 02. Jan 1992
DB NUF Ordinary Shares Deutsche Boerse AG DE EUR 02. Jan 1992
CHIA NUF Ordinary Shares Chi-X Australia AU AUD 02. Jan 1992
OTCPK NFRM.Y SPONSORED ADR Pink Sheets LLC US USD 15. Jan 2016
Number of employees
Current staff
Staff numbers
3,357
Nufarm employees.
Industry
Fertilizers and Agricultural Chemicals
Materials
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/05/16 02:44
End of day share price update: 2019/03/29 00:00
Last estimates confirmation: 2019/05/01
Last earnings filing: 2019/03/19
Last earnings reported: 2019/01/31
Last annual earnings reported: 2018/07/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.